Özler Kenan, Aktaş Erdem, Atay Çiğdem, Yılmaz Barış, Arıkan Murat, Güngör Şafak
Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Orthopedics, Ankara, Turkey.
Dr. Abdurrahman Yurtaslan Onkoloji Training and Research Hospital, Ankara, Turkey.
Acta Orthop Traumatol Turc. 2016 Dec;50(6):670-673. doi: 10.1016/j.aott.2015.11.003. Epub 2016 Dec 5.
To compare the levels of MMP-13 and TNF-α in late stage osteoarthritis, define their predominant pathways and investigate their correlation with McMaster Universities Arthritis Index scores.
A total of 42 patients (mean age 64 ± 8.8) with grade 3 and grade 4 knee osteoarthritis according to Kellegren- Lawrence criteria and who were scheduled for total knee arthroplasty were enrolled in the study. TNF-alpha and MMP-13 levels were measured preoperatively from venous blood samples and intraoperatively from knee synovial fluid via ELISA. Preoperative and 1 month postoperative knee functions were assessed by McMaster Universities Arthritis Index.
Grade 4 synovial fluid MMP-13 (4.76 ± 5.82) was elevated compared to grade 3 (3.95 ± 4.45) (p = 0.438), whereas grade 3 serum MMP-13 (1.128 ± 0.308) was found elevated compared to grade 4 (1.038 ± 0.204) (p = 0.430). Grade 4 serum TNF-α (0.253 ± 0.277) was elevated compared to grade 3 (0.206 ± 0.219) whereas grade 3 synovial fluid TNF-α (0.129 ± 0.052) was elevated compared to grade 4 (0.118 ± 0.014). Positive correlation was observed between synovial fluid MMP-13 levels and postoperative WOMAC scores. Mean serum TNF-α level (0.226 ± 0.246 pg/ml) was found higher compared to synovial level (0.124 ± 1.59), synovial MMP-13 level (4.31 ± 1.24) was found higher compared to serum level (1.089 ± 1.519).
Despite the systemic increase in TNF-α levels concordant with osteoarthritis grade, MMP-13 levels are elevated via local manner with a significant correlation with WOMAC scores.
Level IV, Diagnostic study.
比较晚期骨关节炎中基质金属蛋白酶-13(MMP-13)和肿瘤坏死因子-α(TNF-α)的水平,确定其主要途径,并研究它们与麦克马斯特大学关节炎指数评分的相关性。
根据凯尔格伦-劳伦斯标准,共纳入42例(平均年龄64±8.8岁)3级和4级膝关节骨关节炎且计划行全膝关节置换术的患者。术前通过静脉血样本、术中通过膝关节滑液采用酶联免疫吸附测定法(ELISA)检测TNF-α和MMP-13水平。术前及术后1个月通过麦克马斯特大学关节炎指数评估膝关节功能。
4级滑液MMP-13(4.76±5.82)较3级(3.95±4.45)升高(p = 0.438),而3级血清MMP-13(1.128±0.308)较4级(1.038±0.204)升高(p = 0.430)。4级血清TNF-α(0.253±0.277)较3级(0.206±0.219)升高,而3级滑液TNF-α(0.129±0.052)较4级(0.118±0.014)升高。滑液MMP-13水平与术后西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分呈正相关。血清TNF-α平均水平(0.226±0.246 pg/ml)高于滑液水平(0.124±1.59),滑液MMP-13水平(4.31±1.24)高于血清水平(1.089±1.519)。
尽管TNF-α水平随骨关节炎分级呈系统性升高,但MMP-13水平通过局部方式升高,且与WOMAC评分显著相关。
IV级,诊断性研究。